| scholarly article | Q13442814 |
| P50 | author | Julia C Stingl | Q47824831 |
| David Gurwitz | Q58487946 | ||
| Noam Shomron | Q89341943 | ||
| Metsada Pasmanik-Chor | Q47505014 | ||
| P2093 | author name string | Moshe Rehavi | |
| Ayelet Morag | |||
| Varda Oron-Karni | |||
| Keren Oved | |||
| P2860 | cites work | Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells | Q21263029 |
| microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus | Q24631418 | ||
| A genomewide association study of citalopram response in major depressive disorder | Q24656746 | ||
| Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response | Q28252209 | ||
| Post-transcriptional regulation of the let-7 microRNA during neural cell specification | Q28278730 | ||
| miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants | Q28293486 | ||
| Case-control association study of the close homologue of L1 (CHL1) gene and schizophrenia in the Chinese population | Q28302641 | ||
| Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1 | Q28585131 | ||
| Common genetic variation and human traits | Q29614445 | ||
| A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. | Q30479559 | ||
| Identification of new central nervous system specific mouse microRNAs | Q33237769 | ||
| A novel and universal method for microRNA RT-qPCR data normalization | Q33468633 | ||
| Fine-scale variation and genetic determinants of alternative splicing across individuals | Q33518457 | ||
| Altered microRNA expression following traumatic spinal cord injury | Q33606808 | ||
| Application of housekeeping npcRNAs for quantitative expression analysis of human transcriptome by real-time PCR. | Q33611647 | ||
| Long-term treatment with antidepressants, but not environmental stimulation, induces expression of NP2 mRNA in hippocampus and medial habenula. | Q48275554 | ||
| CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. | Q48277698 | ||
| Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. | Q48405009 | ||
| Stress induces region specific alterations in microRNAs expression in mice. | Q48408364 | ||
| Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy | Q33646358 | ||
| MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling | Q33719554 | ||
| miR-132 mediates the integration of newborn neurons into the adult dentate gyrus | Q33911289 | ||
| MicroRNA-mediated conversion of human fibroblasts to neurons. | Q34200249 | ||
| Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. | Q34229109 | ||
| L1 and CHL1 Cooperate in Thalamocortical Axon Targeting | Q34488140 | ||
| A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression | Q35737324 | ||
| Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation | Q35799841 | ||
| miR-212/132 expression and functions: within and beyond the neuronal compartment | Q36008128 | ||
| MicroRNAs in neuronal function and dysfunction | Q36589809 | ||
| Role of neurotrophic factors in depression | Q36627683 | ||
| Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration | Q36692831 | ||
| Genomic predictors of interindividual differences in response to DNA damaging agents | Q36919909 | ||
| Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression | Q36924856 | ||
| RNA editing in regulating gene expression in the brain | Q37034699 | ||
| Stress downregulates hippocampal expression of the adhesion molecules NCAM and CHL1 in mice by mechanisms independent of DNA methylation of their promoters | Q37081824 | ||
| Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. | Q37119899 | ||
| Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers | Q37159843 | ||
| Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders | Q37262741 | ||
| Identification of genomic regions contributing to etoposide-induced cytotoxicity | Q37271887 | ||
| Use of cell lines in the investigation of pharmacogenetic loci | Q37436398 | ||
| MicroRNAs and pharmacogenomics | Q37736453 | ||
| A review of the current guidelines for depression treatment | Q37776327 | ||
| Dentate gyrus neurogenesis, integration and microRNAs | Q37858674 | ||
| Evolution of microRNA diversity and regulation in animals | Q37957677 | ||
| Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression | Q37969889 | ||
| MicroRNAs and depression | Q37973957 | ||
| Growth factors stimulate expression of neuronal and glial miR-132. | Q39452910 | ||
| Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker | Q39589817 | ||
| Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways | Q39726673 | ||
| Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity | Q40543764 | ||
| Antidepressants and synaptic plasticity: A hypothesis | Q41130859 | ||
| Reduced reactivity to novelty, impaired social behavior, and enhanced basal synaptic excitatory activity in perforant path projections to the dentate gyrus in young adult mice deficient in the neural cell adhesion molecule CHL1. | Q42504618 | ||
| Genome-wide pharmacogenetics of antidepressant response in the GENDEP project | Q42655084 | ||
| Aberrant neuronal connectivity in CHL1-deficient mice is associated with altered information processing-related immediate early gene expression | Q47626181 | ||
| P433 | issue | 10 | |
| P921 | main subject | biomarker | Q864574 |
| microRNA expression | Q60681249 | ||
| P304 | page(s) | 1129-1139 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers | |
| P478 | volume | 13 |
| Q27026147 | Biomarkers predicting antidepressant treatment response: how can we advance the field? |
| Q38444087 | CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study |
| Q37345035 | Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study |
| Q96952537 | Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients |
| Q38156156 | Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia |
| Q34624634 | Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. |
| Q38806729 | Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. |
| Q52331347 | ELLPMDA: Ensemble Learning and Link Prediction for miRNA-Disease Association prediction. |
| Q37699995 | Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications |
| Q38432665 | Gene expression and proliferation biomarkers for antidepressant treatment resistance |
| Q37483043 | Genetic Contributions of Inflammation to Depression |
| Q37281179 | Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants |
| Q38319500 | Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations |
| Q34447816 | Heterogeneity and individuality: microRNAs in mental disorders |
| Q34096374 | Hippocampal gene expression in a rat model of depression after electroacupuncture at the Baihui and Yintang acupoints |
| Q37344763 | Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders |
| Q33812139 | Identification of putative pathogenic SNPs implied in schizophrenia-associated miRNAs |
| Q33591474 | MCMDA: Matrix completion for MiRNA-disease association prediction |
| Q93350625 | MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1 |
| Q21129476 | Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders |
| Q37075039 | MicroRNA as therapeutic targets for treatment of depression |
| Q92533559 | MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression |
| Q47118154 | MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action |
| Q42270340 | MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior? |
| Q56967525 | Neuronal cell adhesion genes and antidepressant response in three independent samples |
| Q58766074 | Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample |
| Q38440275 | Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy |
| Q28541831 | Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy |
| Q54958137 | SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease. |
| Q38161385 | The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p |
| Q89324441 | Therapeutic Antidepressant Potential of NONHSAG045500 in Regulating Serotonin Transporter in Major Depressive Disorder |
| Q92216003 | miRNAs in depression vulnerability and resilience: novel targets for preventive strategies |
| Q47890829 | microRNA-124: a putative therapeutic target and biomarker for major depression. |
Search more.